AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $3.07 and traded as high as $5.14. AIkido Pharma shares last traded at $4.78, with a volume of 184,078 shares trading hands.
AIkido Pharma Stock Performance
The firm has a market capitalization of $26.22 million, a price-to-earnings ratio of -1.23 and a beta of 0.93. The business has a fifty day moving average price of $5.67 and a 200 day moving average price of $3.07.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Recommended Stories
- Five stocks we like better than AIkido Pharma
- Industrial Products Stocks Investing
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Ride Out The Recession With These Dividend Kings
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Health Care Stocks Explained: Why You Might Want to Invest
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
